West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors
West Pharmaceutical Services Inc. closed 43.99% below its 52-week high of $396.75, which the company achieved on April 8th.
Lexicon Pharmaceuticals, Novo Nordisk strike obesity-drug license deal worth up to $1B
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, paving the way for a new type of ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Milestone Pharmaceuticals Shares Hit New Low After FDA Rejects Etripamil
Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...
West Pharmaceutical can be ‘$370 stock’ in bull case, says Evercore ISI
Evercore ISI analyst Daniel Markowitz notes that West Pharmaceutical (WST) shares are down 30% since the company reported Q4 results, but ...
The X Radio3d
Cumberland, WSS Compete At Casey-Westfield Track Meet
CASEY -- Two area boys and girls track teams competed at the Casey-Westfield home meet Monday. Cumberland and Windsor/Stewardson-Srasburg had several athletes finish well. Dieterich had one runner ...